CD24, a promising biomarker in NSCLC
Biomark Med
.
2010 Aug;4(4):495.
doi: 10.2217/bmm.10.77.
Authors
Charles J Rosser
1
,
Steve Goodison
Affiliation
1
Cancer Research Institute, MD Anderson Cancer Center Orlando, Orlando, FL 32827, USA. charles.rosser@orlandohealth.com
PMID:
20701438
DOI:
10.2217/bmm.10.77
No abstract available
Publication types
Comment
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Grants and funding
5 RO1 CA116161-01/CA/NCI NIH HHS/United States